Pfizer’s Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
Title |
Grant Type
Sort ascending
|
Focus Area |
Country |
Application Due Date |
---|---|---|---|---|
Investigating the Value of Using Patient-Reported Outcomes in Oncology Patient Care
|
Research | Oncology | USA | |
Junior Investigator Global ATTR Cardiac Amyloidosis Research
Release Date:
|
Research | Rare Disease | Australia, Canada, France, Germany, Italy, Japan, Korea, Spain | |
Quality Improvement Grants to Improve Identification and Management of Patients with ATTR Amyloidosis
Release Date:
|
Quality Improvement | Rare Disease | Spain | |
Reducing Barriers to Optimal Clinical Care in Breast Cancer
Release Date:
|
Quality Improvement | Oncology | Spain | |
Closing the HRRm Testing Gap in Prostate Cancer Patients
Release Date:
|
Quality Improvement | Oncology | Canada | |
Improving the care and outcomes of residents of Canada living with metastatic NSCLC
Release Date:
Partner: Lung Health Foundation, Lung Cancer Canada, Quebec Lung Association
|
Quality Improvement | Oncology | Canada | |
Improving the Equity and Quality of Cancer Care in Colombia
Release Date:
Partner: The Colombian Association of Oncology and Hematology (ACHO)
|
Quality Improvement | Oncology | Colombia | |
Enhancing Molecular Testing for Metastatic Colorectal Cancer Patients
Release Date:
Partner: Colorectal Cancer Canada (CCC)
|
Quality Improvement | Oncology | Canada | |
IBD QORUS HEALTH EQUITY REQUEST FOR APPLICATIONS (RFA)
Release Date:
Partner: Crohn's & Colitis Foundation
|
Quality Improvement | Inflammation & Immunology | USA | |
2024 Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
Release Date:
Partner: Global Bridges at Mayo Clinic
|
Quality Improvement | Rare Disease | All | |
2024 Inflammatory Bowel Disease (IBD) Fellowship – United States
Release Date:
|
Fellowship | Inflammation & Immunology | USA |
Title |
Grant Type
Sort ascending
|
Focus Area |
Country |
Application Due Date |
---|---|---|---|---|
Real World Evidence of Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
|
Research | Inflammation & Immunology | All | |
2023/2024 Global NASH ASPIRE
Release Date:
|
Research | Internal Medicine | All | |
Diversity in Postmarketing Drug Safety Surveillance
Release Date:
|
Research | Patient Safety | USA | |
Improving Health Equity in IBD through Disparities Research
Release Date:
|
Research | Inflammation & Immunology | All | |
Burden of RSV Disease - Analyzing Local Surveillance Data for Older Adults (EM Geographic Scope)
Release Date:
|
Research | Inflammation & Immunology | All | |
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
Release Date:
|
Research | Rare Disease | Canada | |
Quantifying the Socio-Economic Burden of Disease for Dermatology Patients and Caregivers
Release Date:
|
Research | Inflammation & Immunology | Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Japan, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Spain, Sweden, Switzerland, United Kingdom | |
Ulcerative Colitis (UC) Research
Release Date:
|
Research | Inflammation & Immunology | Albania, Andorra, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Holy See (Vatican City State), Hungary, Iceland, Ireland, Israel, Italy, Korea, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, The Former Yugoslav, Malta, Moldova, Republic of, Monaco, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, San Marino, Slovakia (Slovak Republic), Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom | |
Novel Digital Diagnostic Approaches in Acromegaly and Sickle Cell Disease
Release Date:
|
Research | Rare Disease | USA | |
Alopecia Areata (Global)
Release Date:
|
Research | Inflammation & Immunology | USA | |
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
Release Date:
|
Research | Rare Disease | Canada | |
Global Awards for Research in DMD-AWARD
Release Date:
|
Research | Rare Disease | All |